- Report
- September 2025
- 23 Pages
Bolivia
From €995EUR$1,200USD£900GBP
From €2675EUR$3,227USD£2,419GBP
- Report
- September 2025
- 83 Pages
Azerbaijan
From €2675EUR$3,227USD£2,419GBP
- Report
- September 2025
- 52 Pages
Angola
From €2150EUR$2,594USD£1,945GBP
- Report
- September 2025
- 86 Pages
Bolivia
From €2675EUR$3,227USD£2,419GBP
- Report
- September 2025
- 110 Pages
Austria
From €2675EUR$3,227USD£2,419GBP
- Report
- April 2025
- 28 Pages
Brazil
From €995EUR$1,200USD£900GBP
- Report
- April 2025
- 130 Pages
Brazil
From €2675EUR$3,227USD£2,419GBP
- Report
- October 2024
- 20 Pages
Tunisia
From €995EUR$1,200USD£900GBP
- Report
- October 2024
- 77 Pages
Tunisia
From €2675EUR$3,227USD£2,419GBP
- Report
- October 2024
- 26 Pages
Ukraine
From €995EUR$1,200USD£900GBP
- Report
- October 2024
- 107 Pages
Ukraine
From €2675EUR$3,227USD£2,419GBP
- Report
- October 2024
- 24 Pages
Morocco
From €995EUR$1,200USD£900GBP
- Report
- October 2024
- 101 Pages
Morocco
From €2675EUR$3,227USD£2,419GBP
- Report
- September 2024
- 25 Pages
Philippines
From €995EUR$1,200USD£900GBP
- Report
- September 2024
- 24 Pages
New Zealand
From €995EUR$1,200USD£900GBP
- Report
- September 2024
- 111 Pages
New Zealand
From €2675EUR$3,227USD£2,419GBP
- Report
- September 2024
- 21 Pages
Algeria
From €995EUR$1,200USD£900GBP
- Report
- September 2024
- 73 Pages
Algeria
From €2675EUR$3,227USD£2,419GBP

Allergic Rhinitis is a condition that affects the nose and is caused by an allergic reaction to certain substances. Over the Counter (OTC) drugs are used to treat the symptoms of Allergic Rhinitis, such as sneezing, runny nose, and itchy eyes. OTC drugs are available in a variety of forms, including tablets, capsules, liquids, and nasal sprays. Common active ingredients in OTC drugs for Allergic Rhinitis include antihistamines, decongestants, and corticosteroids. These drugs can be used to reduce inflammation, relieve congestion, and reduce the severity of symptoms.
Some companies in the Allergic Rhinitis Drug market include Johnson & Johnson, GlaxoSmithKline, Novartis, Merck, and Sanofi. Show Less Read more